Finance

Lists
MANGALAM:NSE
Mangalam Drugs and Organics Ltd
29,20 INR
+0,07%
(+0,020) 1D
13-ноя., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for MANGALAM...
Open
28,50 INR
High
29,74 INR
Low
28,50 INR
Mkt. cap
462,66 млн
Avg. vol.
30,32 миң
Volume
7,09 миң
52-wk high
63,00 INR
52-wk low
22,80 INR
EPS
-24,07 INR
Shares outstanding
15,83 млн
No. of employees
319
Open
28,50 INR
High
29,74 INR
Low
28,50 INR
Mkt. cap
462,66 млн
Avg. vol.
30,32 миң
Volume
7,09 миң
52-wk high
63,00 INR
52-wk low
22,80 INR
EPS
-24,07 INR
Shares outstanding
15,83 млн
No. of employees
319
News stories
From web sources and news partners
About Mangalam Drugs and Organics Ltd
CEO-
Employees319
Founded1972
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
2026-ж. сен.
Revenue
583,76 млн
672,87 млн
571,19 млн
795,61 млн
Cost of goods sold
370,74 млн
493,56 млн
331,52 млн
558,92 млн
Cost of revenue
370,74 млн
493,56 млн
331,52 млн
558,92 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
102,64 млн
90,62 млн
89,10 млн
93,28 млн
Operating expense
271,95 млн
280,80 млн
270,38 млн
287,73 млн
Total operating expenses
642,69 млн
774,36 млн
601,90 млн
846,64 млн
Operating income
-58,93 млн
-101,49 млн
-30,71 млн
-51,04 млн
Other non operating income
1,11 млн
-40,69 млн
-
-
EBT including unusual items
-98,35 млн
-132,71 млн
-67,46 млн
-89,91 млн
EBT excluding unusual items
-98,35 млн
-133,12 млн
-67,46 млн
-89,91 млн
Income tax expense
5,00 миң
1,49 млн
8,93 млн
-17,83 млн
Effective tax rate
-0,01%
-1,12%
-13,23%
19,83%
Other operating expenses
124,69 млн
143,61 млн
140,43 млн
153,26 млн
Net income
-98,36 млн
-134,20 млн
-76,39 млн
-72,08 млн
Net profit margin
-16,85%
-19,94%
-13,37%
-9,06%
Earnings per share
-
-
-
-
Interest and investment income
-
9,06 млн
-
-
Interest expense
-40,53 млн
-
-36,75 млн
-38,87 млн
Net interest expenses
-40,53 млн
9,06 млн
-36,75 млн
-38,87 млн
Depreciation and amortization charges
44,61 млн
46,58 млн
40,85 млн
41,19 млн
EBITDA
-25,28 млн
-63,99 млн
14,85 млн
-10,02 млн
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google колдонмолору